Sponsor content
379 result(s) found, displaying 41 to 50
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE enoxaparin sodium 80mg/0.8mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE FORTE enoxaparin sodium 150mg/1mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE enoxaparin sodium 100mg/1mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE enoxaparin sodium 60mg/0.6mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE enoxaparin sodium 40mg/0.4mL solution for injection prefilled syringe.
-
Prescription medicine registrationActive ingredients: cyclizine lactate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX JUNO sugammadex (as sodium) 500 mg/5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HYDROCORTISONE JUNO hydrocortisone (as sodium succinate) 100 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX JUNO sugammadex (as sodium) 200 mg/2 mL solution for injection vial.
-
Australian public assessment report (AusPar)Exarane/Exarane Forte (enoxaparin sodium) has been approved for the prevention of thrombo-embolic disorders, thrombosis and prophylaxis of venous thromboembolism. It has also been approved for the treatment of deep vein thrombosis, unstable angina, non-Q-wave myocardial infarction and acute ST-segment elevation myocardial infarction.